We hypothesize that acetazolamide inadequately improve clinical signs and has no effect on the ventricular volume.
Patients with inadequately controlled T2D improved in their self-care behaviors, self-efficacy, mood and clinical risk during the period of ANC.
In a 13-week, randomized, double-blind, placebo-controlled, parallel-group, phase II dose-ranging study, lixisenatide administered at doses of 5, 10, 20, or 30 μg once daily or twice daily in patients with type 2 diabetes inadequately controlled with metformin significantly improved HbA1c compared with placebo (8).
Adding pioglitazone to insulin in these study patients with type 2 diabetes whose disease was inadequately controlled with insulin monotherapy further improved their glycemic control.
Adjunctive once-daily SPN-804 improved seizure control in patients with inadequately controlled partial-onset seizures.
The combination of biologic agents with traditional therapies may provide improved therapeutic options for patients who inadequately respond to a single drug or when efficacy may be increased with supplementation of another treatment.
Vildagliptin significantly improved glycaemic control in patients with T2DM inadequately controlled with metformin plus glimepiride combination.
Improved antimicrobial drug stewardship is an often cited, but inadequately implemented, intervention for resistance control.
This may be particularly true in inadequately regulated fresh water systems, though quarantines and ballast water rules have improved the situation.
In this regard, a recent analysis of subjects with mild, moderate or severe RI and who were inadequately controlled on insulin therapy showed that linagliptin was well-tolerated and improved glycaemic control without excessive risk of hypoglycaemia 46.
Linagliptin improved glycemic control without weight gain or hypoglycemia in patients with type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone.
